Clearsign Technologies CORP DEF 14A proxy statements
Proxy statements, covering the matters put to shareholders at the annual meeting — board elections, auditor ratification and executive pay.
NASDAQ
ClearSign Technologies Corporation is holding its 2026 Annual Meeting of Stockholders virtually on June 8, 2026, to vote on director elections, auditor appointment, equity incentive plan approval, executive compensation, and potential meeting adjournments.
NASDAQ
ClearSign Technologies Corporation is seeking stockholder approval for a reverse stock split to meet Nasdaq's minimum bid price requirement and avoid potential delisting.
NASDAQ
DEFA14A: Board Committee Reshuffle Announced
A technology company announced changes to the composition of its key board committees, effective late June 2025.
NASDAQ
ClearSign Technologies Corporation has filed its Definitive Proxy Statement (DEFA14A) with the U.S. Securities and Exchange Commission.
NASDAQ
ClearSign Technologies Corporation has scheduled its 2025 Annual Meeting of Stockholders for July 25, 2025, to vote on director elections, auditor appointment, and executive compensation, while actively addressing an invalid director nomination attempt by Jeffrey Feinglas.
NASDAQ
Robert T. Hoffman, Sr., resigned from ClearSign Technologies' board of directors, leading to a vacancy and adjustments to the upcoming annual meeting's voting process.
NASDAQ
ClearSign Technologies modifies its corporate governance structure by vacating the Chairman of the Board position, effective immediately, based on a recommendation from the Nominating and Corporate Governance Committee.
NASDAQ
ClearSign Technologies Corp. will hold its 2024 Annual Meeting on June 25, 2024, and has released proxy materials for stockholders to vote on key proposals.
NASDAQ
ClearSign Technologies is holding its 2024 annual meeting to vote on key proposals including increasing authorized shares, electing directors, and approving executive compensation.